1.
Evid Rep Technol Assess (Summ)
; (115): 1-11, 2005 Feb.
Article
in English
| MEDLINE
| ID: mdl-15810864
Subject(s)
Fatty Acids, Omega-3/therapeutic use , Organ Transplantation , Adult , Child , Data Interpretation, Statistical , Fish Oils , Graft Rejection/prevention & control , Graft Survival/drug effects , Heart Transplantation , Humans , Immunosuppressive Agents/therapeutic use , Kidney Transplantation , Surgical Wound Infection/prevention & control , Treatment Outcome
2.
Evid Rep Technol Assess (Summ)
; (92): 1-8, 2004 Mar.
Article
in English
| MEDLINE
| ID: mdl-15133886
Subject(s)
Arrhythmias, Cardiac/prevention & control , Dietary Supplements , Fatty Acids, Omega-3/pharmacology , Heart/drug effects , Animals , Arrhythmias, Cardiac/mortality , Arrhythmias, Cardiac/physiopathology , Cell Culture Techniques , Disease Models, Animal , Dogs , Fish Oils/pharmacology , Guinea Pigs , Haplorhini , Heart Rate , Ion Channels , Ion Pumps , Meta-Analysis as Topic , Myocardial Contraction , Odds Ratio , Organ Culture Techniques , Rabbits , Rats , Risk Assessment , Swine , Tachycardia, Ventricular/physiopathology , Tachycardia, Ventricular/prevention & control , Ventricular Fibrillation/physiopathology , Ventricular Fibrillation/prevention & control , Ventricular Premature Complexes/physiopathology , Ventricular Premature Complexes/prevention & control
3.
Evid Rep Technol Assess (Summ)
; (94): 1-8, 2004 Mar.
Article
in English
| MEDLINE
| ID: mdl-15133888
Subject(s)
Cardiovascular Diseases/prevention & control , Dietary Supplements , Evidence-Based Medicine , Fatty Acids, Omega-3/pharmacology , Fish Oils/pharmacology , Adult , Age Factors , Aged , Aged, 80 and over , Cardiovascular Diseases/mortality , Cohort Studies , Death, Sudden, Cardiac/prevention & control , Dose-Response Relationship, Drug , Fatty Acids, Omega-3/administration & dosage , Fatty Acids, Omega-3/adverse effects , Fatty Acids, Omega-6/administration & dosage , Fatty Acids, Omega-6/pharmacology , Female , Forecasting , Humans , Male , Middle Aged , Odds Ratio , Primary Prevention , Prospective Studies , Randomized Controlled Trials as Topic , Research , Risk Factors , Sex Factors , Stroke/prevention & control , Time Factors , United States
4.
Evid Rep Technol Assess (Summ)
; (93): 1-6, 2004 Mar.
Article
in English
| MEDLINE
| ID: mdl-15133887
Subject(s)
Cardiovascular Diseases/prevention & control , Dietary Supplements , Evidence-Based Medicine , Fatty Acids, Omega-3/pharmacology , Fish Oils/pharmacology , Adolescent , Adult , Angioplasty, Balloon, Coronary , Biomarkers , Blood Glucose/analysis , Blood Pressure/drug effects , C-Reactive Protein/analysis , Cardiovascular Diseases/blood , Cardiovascular Diseases/epidemiology , Cardiovascular Diseases/physiopathology , Child , Child, Preschool , Cholesterol/blood , Cholesterol, HDL/blood , Cholesterol, LDL/blood , Coronary Restenosis/prevention & control , Coronary Stenosis/therapy , Cross-Over Studies , Data Interpretation, Statistical , Double-Blind Method , Exercise Test , Fasting , Fatty Acids, Omega-3/administration & dosage , Fatty Acids, Omega-3/blood , Female , Fish Oils/administration & dosage , Glucose Tolerance Test , Heart Rate , Humans , Male , Randomized Controlled Trials as Topic , Risk Factors , Thrombosis/prevention & control , Triglycerides/blood
5.
J Hypertens Suppl
; 14(2): S5-7, 1996 Sep.
Article
in English
| MEDLINE
| ID: mdl-8934371
ABSTRACT
UNLABELLED: META-ANALYSIS: A meta-analysis of published randomized control trials of nifedipine in hypertension and stable angina pectoris was performed. RESULTS: The results suggest a formulation-dependent increased risk of mortality and adverse cardiovascular outcomes for monotherapy use in patients with stable angina pectoris. No increased risk was seen in the hypertension studies.